Upcoming Events

In this 48-hour virtual event, MIT will help tackle the most pressing technical, social, and financial issues caused by the Covid-19 outbreak. Participants will form teams on Friday, April 3rd to generate solutions, including proof of concepts and preliminary vision for execution. On Sunday, April 5th, teams will reconvene to present their solutions. The winning team will have the opportunity to co-develop and implement their solution with the support of our partners.

Register now

For the past 19 years, the World Vaccine Congress Washington congress has evolved and grown into the leading vaccines congress globally, with: 350 speakers, 1500 attendees and hundreds of networking opportunities.

Register now

Please join U.S. News for a day of stimulating conversations about the latest wisdom on improving community health. The event, scheduled for April 7 at the National Press Club in Washington, D.C., will bring together public health officials, hospital and health system leaders, business executives, heads of community organizations, and other stakeholders dedicated to advancing effective solutions for building healthier communities. You’ll hear from thought leaders from these arenas who are working together to address the social determinants of health, reduce inequities, invest strategically in community development, and make a lasting difference in the well-being of their populations.

The forum will draw on the data-driven analysis and policy journalism of the Healthiest Communities platform, developed by U.S. News & World Report in collaboration with the Aetna Foundation, an independent charitable and philanthropic affiliate of CVS Health.

Register now

Apps for health, wellness, and disease management are increasingly common across the healthcare ecosystem. Health systems, biotech and pharma, payers, and pharmacy benefits managers are just a few of the industry sectors actively using digital tools to try to improve care delivery and outcomes.

This webinar will discuss emerging lessons and concepts from this space. What is the practical significance of the designation “digital therapeutic?” What are the current regulatory pathways? How does reimbursement actually work? Megan Jones Bell, MD, Chief Science Officer for Headspace, will discuss examples of how these interventions are being integrated into health care and some of the developments on the horizon for this industry.

Register now

Join STAT senior writer Matthew Herper for part one of a three-part digital series on the efforts to develop a coronavirus vaccine. For this conversation, he’ll connect with George Yancopoulos, co-founder, president, and chief scientific officer of Regeneron. They’ll discuss Regeneron’s efforts to develop antibody drugs at speeds never before seen.

Register now

Event focus: the impact of data on patient engagement & experience. A new event brought to you from Corinium, the data & analytics experts.

Register now

In today’s complex health care environment, change is constant.

Providers are challenged to deliver high-quality, high-value care that not only is safe and free from medical errors but also improves patient outcomes.

At the same time, new technology continues to transform the way health care is delivered on almost a weekly basis, making it difficult to contain costs, improve clinical efficiency, and achieve high impact leadership.

To this end Harvard Medical School (HMS) offers Safety, Quality, Informatics and Leadership (SQIL). This comprehensive program delivers the tools you need to become a global leader in health care quality and safety delivery.

SQIL is a one-year certificate program consisting of three in-person, 4-day workshops; dynamic live webinars and pre-recorded lectures; and team-based peer collaboration. This highly interactive program provides participants with direct access to the world’s leading authorities in safety, quality, clinical informatics, and health leadership.

Register now

DIA’s Global Labeling Conference is designed for Labeling, a critical tool for the safe and effective use of prescription drugs, biologics, and medical devices. Its purpose is to convey the essential information needed by providers, patients, and payers to make decisions about product access, prescription, and use. Today’s environment of increasingly complex labeling regulations and guidances is especially challenging for products marketed in multiple regions, which demand worldwide consistency of prescribing and patient information. This conference provides a forum for regulators and industry to update their knowledge of local and global labeling-related policies and to examine the impact of changes on regulatory compliance. Through expert panels and interactive discussions, participants will share approaches, processes, and tools to ensure effective labeling that meets regulatory expectations.

Register now

DH4P is the leading Digital Health conference specifically developed for pharmaceutical and life science commercial organizations.

Co-created by Evolution Road and ExL Events’ Digital Pharma Series teams, this event is designed to help patients, payers, providers, organized systems, ACOs, employers, specialty pharmacies, retail, hospital systems, and digital health companies drive commercial success from opportunities presented through emerging technologies in a rapidly changing global healthcare ecosystem.

Upon inception, DH4P serves to educate life science organizations on how best to leverage digital tools to enhance the commercial model of health and pharma; while also educating patients and bridging the gap between knowledge and information, pre-commercial and commercialization.

You can expect to hear from leading digital health and pharma experts from Merck, Pfizer, Novartis, Sanofi, Roche, Bristol-Myers Squibb, Eli Lilly, and more across the life science value chain.

For 2020: The event explores five leverage models of learning:

Analyze: Analyze equity investments in digital health technology companies

Incubate/accelerate: Evaluate the current climate for supporting digital health startups via internal incubators and accelerators

Commercialize: Profile BD&L partnerships that leverage life science commercial capabilities to bring digital health technologies to market

Collaborate: Develop partnerships that dramatically enhance the value proposition of life science brands to drive commercial impact for those brands by achieving customer goals

Co-develop: Understand how to jointly develop a digital health solution that includes governmental regulatory approval

Register now

The DIA Biostatistics Industry and Regulator Forum is focused on statistical thinking to inform policy, regulation, development, and review of medical products in the context of the current scientific and regulatory environments including pharmaceuticals, biologics and biosimilars, combination products and devices, and generics. Each session will be co-chaired by an FDA/Industry team working side-by-side with today’s experts to present a 360-degree perspective of statistical design, analysis, and methodological approaches to building evidence for pharmaceutical, biologic and biosimilar, combination product and device development, and approval.

Register now

Digital Marketing for Medical Devices West is ExL Events’ flagship west coast event for medical device companies to explore best practices and innovations to improve their digital marketing strategy.

Med device companies will hear from their peers in the industry as well as marketing agencies who will reveal the most effective methods to market their products in a digital age.

Based on the success of their Minneapolis DMMD conference, DMMD West is the leading medical devices marketing event in San Francisco; one of the largest tech hubs in the world. As the medical device industry in this region is expanding at a rapid pace, this event provides a platform to assist this rapid expansion.

From innovation through research and development, marketing and data analytics, communication and branding strategies, and measuring KPIs and ROIs, this event serves to assist your organization, small and large, along your product life cycle.

Reasons to attend:

• Interactive content focused workshop day with two 3-hour workshops delivered by industry leaders who will give insight on how to implement the most effective strategies based on decades of industry experience
• Repositioned in the San Francisco Bay Area, a major breeding ground for tech and device companies, we are projected to gather top device companies from in and around the bay area who will showcase a multitude of product strategies that are innovative and effective
• The only digital marketing for medical device conference located on the west coast and specifically catered to companies based out of the bay area. Providing a platform for industry growth and networking in the bay area

Register now

Join STAT senior writer Matthew Herper for part two of a three-part digital series on the efforts to develop a coronavirus vaccine. For this conversation, he’ll talk with Diana Brainard, senior vice president, HIV and Emerging Viral Infections at Gilead Sciences. They’ll discuss what needs to be done to develop antiviral treatments.

Register now

Health care is being dramatically transformed by several converging forces. These include the accelerating growth of machine learning, genomics and precision medicine, digital technologies, changes in reimbursement, and a renewed focus on the patient at the center of care. Regardless of your role or the specific focus of your organization, these forces will shape the challenges and opportunities for industry stakeholders across all health care sectors. Business and science leaders must operate at the complex intersection of these disruptions and possess a comprehensive understanding of the health care ecosystem. This is critical for their innovations to succeed and meet important unmet needs of patients, providers, or payers. Led by Dr. Stanley Shaw, Associate Dean of Executive Education at Harvard Medical School, this program will be taught by Harvard Medical School faculty who are leaders and distinguished innovators in their fields. Through their research and clinical practice, they possess broad expertise and cutting-edge knowledge. A certificate of completion will be offered for this program.

Register now